Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
38 studies found for:    " March 05, 2008":" April 04, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed HORIZONS HIV Intervention
Conditions: HIV Infections;   Sexually Transmitted Diseases
Interventions: Behavioral: HORIZONS HIV Intervention;   Behavioral: enhanced standard-of-care
22 Terminated Reactogenicity and Immunogenicity of Vaginal CNgp140
Conditions: HIV Infections;   Acquired Immune Deficiency Syndrome
Interventions: Biological: HIV glycoprotein CN54gp140 (vaccine);   Biological: Carbopol 974
23 Completed Effects Of Food And Dose Regimen On The Antiviral Effects Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus
Condition: HIV
Interventions: Drug: Maraviroc (UK-427,857);   Other: Placebo
24 Completed Effectiveness of a Risk Reduction Program in Preventing the Transmission of HIV and Sexually Transmitted Diseases in African-American Couples
Conditions: HIV Infections;   Sexually Transmitted Disease
Interventions: Behavioral: Eban HIV/STD Risk Reduction Intervention;   Behavioral: Eban Health Promotion Intervention
25 Completed Evaluation of 2 Interferon γ Assays in the Diagnosis of Latent Tuberculosis in HIV-infected Patients.ANRS EP 40 QUANTI SPOT
Conditions: HIV Infections;   Tuberculosis
Interventions: Device: QuantiFERON TB Gold In-Tube;   Device: T-SPOT.TB®
26 Completed Effectiveness of an Abstinence-Only HIV/Sexually Transmitted Disease Risk-Reduction Intervention for Young African-American Adolescents
Conditions: HIV Infections;   Sexually Transmitted Diseases
Interventions: Behavioral: Abstinence-only HIV/STD risk-reduction intervention;   Behavioral: Safer-sex-only HIV/STD risk-reduction intervention;   Behavioral: Long comprehensive HIV/STD risk-reduction intervention;   Behavioral: Short comprehensive HIV/STD risk-reduction intervention;   Behavioral: Health promotion control intervention
27 Completed
Has Results
Raltegravir Therapy for Women With HIV and Fat Accumulation
Conditions: HIV Infections;   Lipodystrophy
Intervention: Drug: raltegravir
28 Completed Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and Vomiting
Conditions: Highly Active Antiretroviral Therapy (HAART)-Related Nausea and Vomiting;   HIV Infections
Interventions: Drug: Dronabinol;   Drug: Placebo
29 Completed Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in Vietnam
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: rifabutin in combination with lopinavir boosted by ritonavir - dosing schedule 1;   Drug: rifabutin in combination with lopinavir boosted by ritonavir - dosing schedule 2
30 Unknown  HIV-HBV Co-Infection and Liver Disease
Conditions: HIV Infections;   HIV-HBV Co-Infection
Intervention:
31 Completed Effectiveness of HIV/Sexually Transmitted Infection Training for Physicians in China
Conditions: HIV Infections;   Gonorrhea;   Chlamydia
Interventions: Behavioral: Physician Ai Shi Zi training;   Drug: Standard care;   Behavioral: Patient risk-reduction counseling
32 Completed Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients
Condition: Human Immunodeficiency Virus
Intervention: Drug: lopinavir/ritonavir
33 Completed
Has Results
Drug Interaction Study
Condition: Antivirals/HIV
Interventions: Drug: Rifabutin;   Drug: Rifabutin + Atazanavir + Ritonavir
34 Completed
Has Results
Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss
Conditions: HIV Infections;   Cachexia;   Anorexia;   AIDS Wasting Syndrome;   HIV Wasting Syndrome
Interventions: Drug: Megestrol acetate oral suspension nanocrystal dispersion 115 mg/mL;   Drug: Megestrol acetate oral suspension 40 mg/mL
35 Completed Phase 2B Dose-Ranging Study of PAC113 Mouthrinse in HIV Seropositive Individuals With Oral Candidiasis
Condition: Oral Candidiasis
Intervention: Drug: PAC113
36 Completed
Has Results
Exercise and Pioglitazone for HIV-Metabolic Syndromes
Conditions: HIV Infections;   Type 2 Diabetes;   Obesity;   HIV;   AIDS;   Cardiovascular Disease;   Lipodystrophy
Interventions: Drug: Pioglitazone;   Behavioral: Exercise training
37 Terminated Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients
Conditions: Hepatitis C;   Depressive Disorder, Major;   Depressive Disorder;   Depression;   HIV Infections
Interventions: Behavioral: Hepatitis C educational support groups;   Behavioral: Cognitive Behavioral Therapy skills based group sessions
38 Active, not recruiting Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma
Condition: Lymphoma
Interventions: Drug: carmustine;   Drug: cyclophosphamide;   Drug: etoposide;   Other: pharmacological study;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-38) Next Page   
Study has passed its completion date and status has not been verified in more than two years.